Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Matsuda

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Cancer Chemotherapy and Pharmacology|January 14, 2011
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinomaMakiko Mori, Mamoru Tsukuda, Hideki Matsuda, et al.
Anticancer Research|January 31, 2012
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinomaMasanori Komatsu, Mamoru Tsukuda, Hideki Matsuda, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2009
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neckMamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, et al.
Nihon Jibiinkoka Gakkai Kaiho|March 16, 2005
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]Hideaki Katori, Mamoru Tsukuda, Junichi Ishitoya, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidityMamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Cancer Chemotherapy and Pharmacology|January 14, 2011
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinomaMakiko Mori, Mamoru Tsukuda, Hideki Matsuda, et al.
Anticancer Research|January 31, 2012
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinomaMasanori Komatsu, Mamoru Tsukuda, Hideki Matsuda, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2009
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neckMamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, et al.
Nihon Jibiinkoka Gakkai Kaiho|March 16, 2005
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]Hideaki Katori, Mamoru Tsukuda, Junichi Ishitoya, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidityMamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
Pageof 7